All lobbying filings
Thorn Run Partners
Thorn Run Partners filed a Q3 report for Pharmaceutical Research and Manufacturers of America on October 20, 2026, reporting $40,000 in lobbying income.
Lobbying for Pharmaceutical Research and Manufacturers of America · Pharmaceutical Industry Association
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
2
-
BEAU SCHUYLERPreviously held: Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre
-
YUL EDWARDSPreviously held: Legislative Assistant/Chief of Staff, Rep. Danny K. Davis; Legislative Director, Rep. Frank Ballance, Jr.
Government bodies contacted
3
Lobbying activity
1
Promoting pharmaceutical research and development and ensuring access to medicines.